| 7:00 AM – 5:45 PM |
Registration and Information |
|
| 6:45 AM – 7:45 AM |
Breakfast |
|
| 7:45 AM – 8:00 AM |
Introduction to General Session – Program Overview
David S. Geldmacher, MD, Program Chair |
|
| 8:00 AM – 9:00 AM |
Keynote: Why the New Drugs Haven’t Worked
David S. Geldmacher, MD |
|
| 9:00 AM – 10:00 AM |
The Amnestic Dutchman Revisited
Daniel D. Christensen, MD |
|
| 10:00 AM – 10:15 AM |
Break |
|
| 10:15 AM – 11:15 AM |
Evaluation of AD With Structural MRI and CSF
Philip Scheltens, MD, PhD |
|
| 11:15 AM – 11:30 AM |
Closing Remarks and Instructions for the Track Breakouts
David S. Geldmacher, MD |
|
| 11:30 AM – 12:30 PM |
Lunch |
|
| |
Track I |
Track II |
Track III |
|
Primary Care |
Psychiatry |
Neurology |
 |
|
|
|
| 12:30 PM – 12:45 PM |
Welcome and Introduction
Peter J. Lin, MD, Chair |
Welcome and
Introduction
Gary W. Small, MD, Chair |
Welcome and Introduction
Stephen P. Salloway, MD, MS, Chair |
|
| 12:45 PM – 1:45 PM |
Diagnosis of Dementia
Peter J. Lin, MD |
Differential Diagnosis of Dementia
David S. Geldmacher, MD |
Update on MCI
Stephen P. Salloway, MD, MS |
|
| 1:45 PM – 2:45 PM |
Treatment Strategies Across the Spectrum
of AD
Ann M. Hake, MD |
Management of Agitation and Psychosis in AD
Pierre N. Tariot, MD |
Amyloid Therapeutics
Norman R. Relkin, MD, PhD |
|
| 2:45 PM – 3:00 PM |
Break |
|
| 3:00 PM – 4:00 PM |
Comorbidities/Triggers in Patients With Dementia
Diana R. Kerwin, MD |
Supportive Psychotherapy for Patients’ Families
Peter V. Rabins, MD, MPH |
Diagnostics and Therapeutics for FTD-Spectrum Disorders
Bruce L. Miller, MD |
|
| 4:00 PM – 5:00 PM |
Frequently Asked Questions About Dementia
Sandra Liliana
Oakes, MD |
Herbs, Supplements, and Medical Foods for Memory Loss: Snake Oil or Smart Choices
P. Murali Doraiswamy, MD |
Amyloid Imaging: Now and in the Future
Keith A. Johnson, MD |
|
| 5:00 PM – 5:15 PM |
Concluding Remarks
Peter J. Lin, MD |
Concluding Remarks
Gary W. Small, MD |
Concluding Remarks
Stephen P. Salloway, MD, MS |
|
